Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Economy & Forex

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Pfizer-BioNTech seeks full marketing approval from UK for COVID-19 vaccine

12/02/2020 | 11:59am EST
FILE PHOTO: Pfizer vaccine photo illustration

LONDON (Reuters) - Pfizer is seeking full marketing authorisation from Britain for its COVID-19 vaccine, an executive said on Wednesday as the U.S. drugmaker gears up to deliver by the weekend the first shots following approval for emergency use in the country.

The application for full approval is "in parallel" with emergency use approval (EUA), said Berkeley Phillips, medical director of Pfizer UK, in a briefing.

He said regulators will review the same data provided for the emergency use by Pfizer and its partner BioNTech for the full approval. He did not say when that decision may come.

Deliveries, which could land in British warehouses as soon as the weekend, could not have started until the regulators had given their go ahead, he said. Regulators will assess each batch of the vaccine for quality.

Other countries are looking at possibly following in Britain's footsteps and applying for emergency use in an effort to speed up access to the vaccine, said Ralf Rene Reinert, Pfizer Vaccines' vice president, regional lead medical and scientific affairs. He declined to name countries that are doing this.

There is no cap on volumes delivered under the EUA, said Ben Osborn, manager of Pfizer UK.

(Reporting by Alistair Smout and Kate Kelland in London, John Miller in Zurich and Ludwig Burger in Frankfurt; Writing by Josephine Mason; Editing by Louise Heavens, Kirsten Donovan)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
BIONTECH SE -1.44% 103.215 Delayed Quote.28.93%
PFIZER INC. -0.63% 36.5099 Delayed Quote.-0.22%
Latest news "Economy & Forex"
01:47pAmazon.com consumer ceo (not amazon.com inc ceo) offers to help with vaccine efforts in message to u.s. president joe biden - letter
RE
01:45pEU wheat eases as grain rally stalls; Algeria tender assessed
RE
01:42pAmazon.com inc ceo offers to help with vaccine efforts in message to u.s. president joe biden - letter
RE
01:40pCanadian annual inflation rate slows in December amid renewed COVID-19 restrictions
RE
01:26pCHRYSAOR : Norge awarded licenses in Norwegian APA 2020 Licensing Round
PU
01:23pIn hidden message on White House website, Biden calls for coders
RE
01:18pCOMING SOON : The January 2021 Update of the World Economic Outlook will be released on January 26 at 8:00 a.m. ET. Tune in to the press conference with Gita Gopinath, Economic Counselor and Director of the Research Department; Petya Koeva Brooks, Deputy Director of the Research Department; and Malhar Nabar, Division Chief Research Department
PU
01:15pUk pm johnson says our hope is that the united states joins us on net zero by 2050
RE
01:13pUK PM JOHNSON SAYS UK AND US HAVE FANTASTIC COMMON Agenda AS U.S. PRESIDENT BIDEN TAKES OFFICE
RE
01:12pUK's Johnson says record COVID-19 death figures are appalling
RE
Latest news "Economy & Forex"